prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype LumB, Procedure Date: Procedure Physician: Attending Physician/Copies To: PATIENT HISTORY: DATE of LMP: DATE or LAST DELIVERY. PRE-OP DIAGNOSIS: L BREAST CA. POST-OP DIAGNOSIS: SAME-. OPERATIVE PROCEDURE: L MRM. CLINICAL HISTORY: MATERIAL SUBMITTED: LEFT (MOD) RADICAL MASTECTOMY, PROCUREMENT BY SURGICAL PROCEDURE. and axillary contents. ADDENDA: Addendum. FINAL DIAGNOSIS: ER/PR. IMMUNOPEROXIDASE IDENTIEICATION OF ESTROGEN AND PROGESTERONE RECEPTORS IS CARRIED OUT ON SLIDE "A2". DISTINCT INTRANUCLEAR STAINING IS IDENTIFIED FOR ESTROGEN RECEPTOR (50%) AND PROCESTERONE RECEPTOR (40%) . THEREFORE, BOTH ARE INTERPRITED AS POSITIVE. BER-2/NEU. c-erb82 (HER-2/NEU) IMMUNOSTAINING IS CARRIED OUT ON. (BREAST CANCER) USING A. 1:300 DILUTION OF DAKO'S POLYCLONAL ANTIBODY A485 (DIRECTED AGAINST THE INTRACELLULAR DOMAIN OF c-erba2). WITHOUT ANTIGEN RETRIEVAL DISTINCT COMPLETE MEMBRANE STAINING IS IDENTIFIED IN 70% OF TUMOR CELLS. THEREFORE, o-erba2 (HER-2/NEU) IS INTERPRETED AS POSITIVE (SCORE 3+). My signature is attestation that I have ppersonallyreviewed the submitted material(s) andthe final. diagnosis reflects that evaluation. FINAL DIAGNOSIS: LEFT BREAST, MODIFIED RADICAL MASTECTOMY: - INFILTRATING, POORLY DITYERENTIATED DUCT CARCINOMA, 4.7 BY 2.5 BY 2.0 CM, INVOLVING ALL FOUR QUADRANTS. - NOTTINGHAM SCORE: 8/9 (TUBULES=3/3, NUCLEAR ATYPIA=3/3, MITOTIC INDEX=2/3). - DUCTAL CARCINOMA IN SITU INVOLVES <5% OF TOTAL TUMOR. - TUMOR EXTENDS TO INVOLVE DERMIS OF NIPPLE, DERMAL LYMPROVASCULAR PERMEATION IS PRESENT. - NIPPLE AND ADJACENT SKIN INVOLVED BY PAGET'S DISEASE. - MARGINS OF RESECTION ARE NEGATIVE FOR TUMOR, HOWEVER; TUMOR EXTENDS TO WITHIN 0.2 CM or THE DEEP NARGIN. - FIBROCYSTIC CHANGES. - DUCT ECTASIA. - NON-TUMOR ASSOCIATED MICROCALCIFICATIONS. - SIX (6) OUT or NINETEEN (19) LYMPH NODES, POSITIVE FOR METASTATIC CARCINOMA, MULTIPLE FOCI OF. EXTRANCOAL. TUMOR EXTENSION ARE SEEN. NOTE: ER/PR immunoperoxidase assay and Her-2/NEU testing will be performed on block "A2".

expanded version (tokens=1111) : 
 The breast pathology report indicates the following information:

1. Histological classification: Infiltrating, poorly differentiated duct carcinoma, with ductal carcinoma in situ involving <5% of the total tumor. The subtype is LumB.
2. Histological grade: Nottingham Score is 8/9 (Tubules=3/3, Nuclear Atypia=3/3, Mitotic Index=2/3).
3. Necrosis: No mention of necrosis.
4. Tumor infiltrating lymphocytes: No mention of tumor infiltrating lymphocytes.
5. Lymphovascular invasion: Yes, dermal lymphovascular permeation is present.
6. Calcification: Non-tumor associated microcalcifications are present.
7. Receptor status: ER/PR immunoperoxidase assay shows distinct intranuclear staining for estrogen receptor (50%) and progesterone receptor (40%). Therefore, both are interpreted as positive. Her-2/Neu immuno-staining shows distinct complete membrane staining in 70% of tumor cells, therefore, Her-2/Neu is interpreted as positive (score 3+).
8. Ancillary testing results: No other ancillary testing results provided in the report.

Overall, the report suggests that the patient has LumB subtype of infiltrating, poorly differentiated duct carcinoma with lymphovascular invasion and positive ER/PR and Her-2/Neu receptors. The tumor involves all four quadrants of the breast,

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=1263) : 
 The breast pathology report shows LumB type infiltrating, poorly differentiated duct carcinoma involving all four quadrants of the left breast, with ductal carcinoma in situ <5% of total tumor. Nottingham Score is 8/9. The tumor is positive for ER/PR and Her-2/Neu receptors and has lymphovascular invasion. Additionally, Paget's disease is present in nipple and adjacent skin, while six out of nineteen lymph nodes are positive for metastatic carcinoma with extranodal tumor extension seen.

